Extracellular Vesicles as Nanoparticle Delivery Vectors in Cancer Therapy
Nano Letters · 2026
DOI: 10.1021/acs.nanolett.6c00911 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nano Letters, 2026. Verfasst von Maria Sancho-Albero und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Campus Rio Ebro, Edificio I+D, C/Poeta Mariano Esquillor, s/n, …. Hauptthemen laut MEDLINE: Neoplasms, Extracellular Vesicles, Nanoparticles, Drug Delivery Systems. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Severo Ochoa Excellence Program, Spanish Ministry of Science, Innovation and Universities from the Spanish Government.
Abstract (Originalsprache)
Three decades after the approval of the first cancer nanomedicine, low (<1%) tumor delivery remains the central unsolved challenge in nanoparticle (NP)-based therapy. This barrier has prompted a research shift toward biologically derived delivery systems able to reduce immune clearance while preserving tumor-homing capabilities. In particular, extracellular vesicles (EVs) seem obvious candidates on account of their intrinsic biocompatibility, cell-specific tropism, and biological functionality. In this mini-review, we critically analyze EVs as nanoparticle delivery vectors in cancer therapy. We describe current EV engineering approaches, including loading methodologies, surface modification strategies, and the development of artificial or biomimetic EVs, highlighting technical, scalability, and characterization challenges. We also summarize key in vitro and in vivo results, addressing encapsulation strategy, biodistribution, and therapeutic outcomes. From this discussion, we outline research needs that must be addressed to develop EV–NP hybrids as tools to overcome the delivery challenge in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Campus Rio Ebro, Edificio I+D, C/Poeta Mariano Esquillor, s/n, Zaragoza 50018, Spain.
- Department of Chemical and Environmental Engineering, University of Zaragoza, Campus Rio Ebro, C/María de Luna, 3, Zaragoza 50018, Spain.
- Networking Research Center in Biomaterials, Bioengineering and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, Madrid 28029, Spain.
- Instituto de Investigación Sanitaria (IIS) de Aragón, Avenida San Juan Bosco, 13, Zaragoza 50009, Spain.
- Departamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias, Universidad de Zaragoza, 50009 Zaragoza, Spain.
- Facultad de Ciencias de la Salud y del Deporte, Universidad de Zaragoza; Plaza Universidad 3, Huesca 22002, Spain.
ORCID-Profile: Maria Sancho-Albero, Jose L Hueso, Victor Sebastian, Jesus Santamaria
Förderung
- European Research Council
- Severo Ochoa Excellence Program
- Spanish Ministry of Science, Innovation and Universities from the Spanish Government
Zitieren
APA
Sancho-Albero, M., Martín-Pardillos, A., Hueso, J. L., Sebastian, V., & Santamaria, J. (2026). Extracellular Vesicles as Nanoparticle Delivery Vectors in Cancer Therapy. Nano Letters. https://doi.org/10.1021/acs.nanolett.6c00911
Vancouver
Sancho-Albero M, Martín-Pardillos A, Hueso JL, Sebastian V, Santamaria J. Extracellular Vesicles as Nanoparticle Delivery Vectors in Cancer Therapy. Nano Letters. 2026. doi:10.1021/acs.nanolett.6c00911
BibTeX
@article{SanchoAlbero2026,
author = {Sancho-Albero, Maria and Martín-Pardillos, Ana and Hueso, Jose L and Sebastian, Victor and Santamaria, Jesus},
title = {Extracellular Vesicles as Nanoparticle Delivery Vectors in Cancer Therapy},
journal = {Nano Letters},
year = {2026},
doi = {10.1021/acs.nanolett.6c00911}
}
EUVIMED